Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Picat

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Human Genetics|January 1, 1980
Inherited erythrocyte phosphofructokinase deficiency: molecular mechanismJ Etiemble, C Picat, J Siméon, et al.
British Journal of Haematology|July 1, 1979
Red blood cell enzyme abnormalities in patients treated with chemotherapyJ Etiemble, J F Bernard, C Picat, et al.
Science (New York, N.Y.)|November 7, 1986
Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyriaH de Verneuil, B Grandchamp, C Beaumont, et al.
American Journal of Hematology|October 1, 1984
Erythrocytic pyruvate kinase deficiency and hemolytic anemia inherited as a dominant traitJ Etiemble, C Picat, D Dhermy, et al.
Biochimica Et Biophysica Acta|September 13, 1983
A liver-type mutation in a case of pronounced erythrocyte phosphofructokinase deficiency without clinical expressionJ Etiemble, J Simeon, H A Buc, et al.
Nucleic Acids Research|August 25, 1989
A point mutation G----A in exon 12 of the porphobilinogen deaminase gene results in exon skipping and is responsible for acute intermittent porphyriaB Grandchamp, C Picat, F de Rooij, et al.
Human Genetics|August 1, 1991
Genetic heterogeneity of the porphobilinogen deaminase gene in Swedish families with acute intermittent porphyriaJ S Lee, G Lundin, L Lannfelt, et al.
Human Genetics|January 1, 1988
Prevalence of the 281 (Gly----Glu) mutation in hepatoerythropoietic porphyria and porphyria cutanea tardaH de Verneuil, J Hansen, C Picat, et al.
American Journal of Human Genetics|August 1, 1991
Molecular heterogeneity of acute intermittent porphyria: identification of four additional mutations resulting in the CRIM-negative subtype of the diseaseM H Delfau, C Picat, F De Rooij, et al.
Journal of Biochemical and Biophysical Methods|May 1, 1989
An efficient laboratory made apparatus for DNA amplificationO Bertrand, M H Delfau, M Garbarz, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Human Genetics|January 1, 1980
Inherited erythrocyte phosphofructokinase deficiency: molecular mechanismJ Etiemble, C Picat, J Siméon, et al.
British Journal of Haematology|July 1, 1979
Red blood cell enzyme abnormalities in patients treated with chemotherapyJ Etiemble, J F Bernard, C Picat, et al.
Science (New York, N.Y.)|November 7, 1986
Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyriaH de Verneuil, B Grandchamp, C Beaumont, et al.
American Journal of Hematology|October 1, 1984
Erythrocytic pyruvate kinase deficiency and hemolytic anemia inherited as a dominant traitJ Etiemble, C Picat, D Dhermy, et al.
Biochimica Et Biophysica Acta|September 13, 1983
A liver-type mutation in a case of pronounced erythrocyte phosphofructokinase deficiency without clinical expressionJ Etiemble, J Simeon, H A Buc, et al.
Nucleic Acids Research|August 25, 1989
A point mutation G----A in exon 12 of the porphobilinogen deaminase gene results in exon skipping and is responsible for acute intermittent porphyriaB Grandchamp, C Picat, F de Rooij, et al.
Human Genetics|August 1, 1991
Genetic heterogeneity of the porphobilinogen deaminase gene in Swedish families with acute intermittent porphyriaJ S Lee, G Lundin, L Lannfelt, et al.
Human Genetics|January 1, 1988
Prevalence of the 281 (Gly----Glu) mutation in hepatoerythropoietic porphyria and porphyria cutanea tardaH de Verneuil, J Hansen, C Picat, et al.
American Journal of Human Genetics|August 1, 1991
Molecular heterogeneity of acute intermittent porphyria: identification of four additional mutations resulting in the CRIM-negative subtype of the diseaseM H Delfau, C Picat, F De Rooij, et al.
Journal of Biochemical and Biophysical Methods|May 1, 1989
An efficient laboratory made apparatus for DNA amplificationO Bertrand, M H Delfau, M Garbarz, et al.
Pageof 4